Cellcept and Nitrofurantoin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Nitrofurantoin (nitrofurantoin, macrocrystalline). Common drug interactions include liver injury among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Nitrofurantoin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Nitrofurantoin?

Nitrofurantoin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 4,837 Nitrofurantoin users. Check the latest studies of Nitrofurantoin.



On Jul, 09, 2026

17 people who take Cellcept and Nitrofurantoin together, and have interactions are studied.

Cellcept and Nitrofurantoin drug interactions.

What are the common drug interactions of Cellcept and Nitrofurantoin, by gender? *:

female:

  1. Liver injury
  2. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  3. Adverse drug reaction
  4. Asthenia (weakness)
  5. Atrophy (wasting away of a part of the body)
  6. Blood creatinine increased
  7. Epstein-barr viraemia
  8. Herpes zoster
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Performance status decreased

male:

  1. Asthenia (weakness)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema peripheral (superficial swelling)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Pneumonia
  7. Pruritus (severe itching of the skin)
  8. Pyrexia (fever)
  9. Renal impairment (severely reduced kidney function)
  10. Upper respiratory tract infection

What are the common drug interactions of Cellcept and Nitrofurantoin, by age (0-1 to 60+)? *:

0-1:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Blood creatinine increased
  3. Blood culture positive
  4. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  5. Productive cough
  6. Pyrexia (fever)
  7. Upper respiratory tract infection

2-9:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Gamma-glutamyltransferase increased

10-19:

  1. Atrophy (wasting away of a part of the body)
  2. Blood creatinine increased
  3. Epstein-barr viraemia
  4. Herpes zoster
  5. Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Urinary retention (the inability to completely or partially empty the bladder)
  8. Kidney transplant rejection

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cytomegalovirus infection
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Muscular weakness (muscle weakness)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Blood creatine phosphokinase increased
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Liver injury
  9. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  10. Post procedural infection

60+:

  1. Asthenia (weakness)
  2. Dehydration (dryness resulting from the removal of water)
  3. Hypokalaemia (low potassium)
  4. Nausea (feeling of having an urge to vomit)
  5. Oedema peripheral (superficial swelling)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Pneumonia
  8. Pruritus (severe itching of the skin)
  9. Renal impairment (severely reduced kidney function)
  10. Vomiting

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 23.53%
  2. Rectal Cancer Metastatic (cancer of rectum spreads to other): 2 people, 11.76%
  3. Immunodeficiency Disorders: 1 person, 5.88%
  4. Gait Disturbance: 1 person, 5.88%
  5. Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Nitrofurantoin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Nitrofurantoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrofurantoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrofurantoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and nitrofurantoin, macrocrystalline (the active ingredients of Cellcept and Nitrofurantoin, respectively), and Cellcept and Nitrofurantoin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: